Cargando…

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma

Serum cytokine and chemokine networks may reflect the complex systemic immunological interactions in cancer patients. Studying groups of cytokines and their networks may help to understand their clinical biology. A total of 178 cases of ovarian cancer were analyzed in this study, including 73 high-g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yabuno, Akira, Matsushita, Hirokazu, Hamano, Tetsutaro, Tan, Tuan Zea, Shintani, Daisuke, Fujieda, Nao, Tan, David S. P., Huang, Ruby Yun-Ju, Fujiwara, Keiichi, Kakimi, Kazuhiro, Hasegawa, Kosei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595156/ https://www.ncbi.nlm.nih.gov/pubmed/33116254 http://dx.doi.org/10.1038/s41598-020-75536-1

Ejemplares similares

Association between effector-type regulatory T cells and immune checkpoint expression on CD8(+) T cells in malignant ascites from epithelial ovarian cancer
por: Sato, Sho, et al.
Publicado: (2022)

Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
por: Ogasawara, Aiko, et al.
Publicado: (2020)

Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma
por: Sato, Masakazu, et al.
Publicado: (2022)

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2020)

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo
por: Ikeda, Yuji, et al.
Publicado: (2020)

A pilot study of mobile digital colposcopy in Japanese patients with cervical intraepithelial neoplasm
por: Sato, Masakazu, et al.
Publicado: (2021)

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
por: Nishikawa, Tadaaki, et al.
Publicado: (2017)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
por: Yoshida, Hiroyuki, et al.
Publicado: (2015)

Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
por: Tan, Tuan Zea, et al.
Publicado: (2019)

CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
por: Heong, Valerie, et al.
Publicado: (2021)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma
por: Beck, Richard J., et al.
Publicado: (2023)

Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells
por: Nagasawa, Saya, et al.
Publicado: (2022)

Comprehensive analysis of cytokine adsorption properties of polymethyl methacrylate (PMMA) membrane material
por: Kishikawa, Tatsuya, et al.
Publicado: (2022)

Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma Via Oxidative Stress and Iron−Sulfur Cluster Biogenesis Deficit
por: Novera, Wisna, et al.
Publicado: (2020)

Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing
por: Nagasawa, Saya, et al.
Publicado: (2019)

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype
por: Tan, Tuan Zea, et al.
Publicado: (2015)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
por: Wada, Ikuo, et al.
Publicado: (2014)

Denatured Mammalian Protein Mixtures Exhibit Unusually High Solubility in Nucleic Acid-Free Pure Water
por: Futami, Junichiro, et al.
Publicado: (2014)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
por: Kondo, Eiji, et al.
Publicado: (2020)

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m(2) versus 40 mg/m(2) in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
por: Motohashi, Takashi, et al.
Publicado: (2020)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
por: Sato, Sho, et al.
Publicado: (2017)

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53
por: Makii, Chinami, et al.
Publicado: (2016)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

Correction: Sundararajan, V., et al. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

The FZD7‐TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma
por: Tan, Ming, et al.
Publicado: (2019)

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole‐exome sequencing
por: Karasaki, Takahiro, et al.
Publicado: (2017)

Advanced Mucinous Adenocarcinoma Arising from a Mature Cystic Teratoma: A Case Report and Literature Review
por: Miyasaka, Aki, et al.
Publicado: (2016)

Detection and Tracking of NY-ESO-1-Specific CD8(+) T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient
por: Miyai, Manami, et al.
Publicado: (2015)

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE‐100
por: Nishio, Shin, et al.
Publicado: (2020)

The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
por: Chung, Vin Yee, et al.
Publicado: (2019)

Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
por: Yano, Mitsutake, et al.
Publicado: (2019)

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas
por: Uehara, Yuriko, et al.
Publicado: (2015)

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2tvnrk13adsr5t14d7eepif7rk